Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca A Burrell

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Current Opinion in Genetics & Development|March 25, 2014
The evolution of the unstable cancer genomeRebecca A Burrell, Charles Swanton
Trends in Cancer|July 26, 2017
Re-Evaluating Clonal Dominance in Cancer EvolutionRebecca A Burrell, Charles Swanton
Molecular Oncology|August 5, 2014
Tumour heterogeneity and the evolution of polyclonal drug resistanceRebecca A Burrell, Charles Swanton
Cancer Biology & Therapy|October 10, 2009
Advances in personalized therapeutics in non-small cell lung cancer: 4q12 amplification, PDGFRA oncogene addiction and sunitinib sensitivityCharles Swanton, Rebecca A Burrell
Breast Cancer Research : BCR|February 25, 2011
Breast cancer genome heterogeneity: a challenge to personalised medicine?Charles Swanton, Rebecca A Burrell, P Andrew Futreal
Cell Cycle (Georgetown, Tex.)|October 7, 2009
Chromosomal instability: a composite phenotype that influences sensitivity to chemotherapySarah E McClelland, Rebecca A Burrell, Charles Swanton
Nature|September 20, 2013
The causes and consequences of genetic heterogeneity in cancer evolutionRebecca A Burrell, Nicholas McGranahan, Jiri Bartek, et al.
Current Biology : CB|February 22, 2014
Response to Bakhoum et alRebecca A Burrell, Sarah E McClelland, Jiri Bartek, et al.
EMBO Reports|May 19, 2012
Cancer chromosomal instability: therapeutic and diagnostic challengesNicholas McGranahan, Rebecca A Burrell, David Endesfelder, et al.
Annual Review of Genetics|October 9, 2014
Cancer: evolution within a lifetimeMarco Gerlinger, Nicholas McGranahan, Sally M Dewhurst, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Current Opinion in Genetics & Development|March 25, 2014
The evolution of the unstable cancer genomeRebecca A Burrell, Charles Swanton
Trends in Cancer|July 26, 2017
Re-Evaluating Clonal Dominance in Cancer EvolutionRebecca A Burrell, Charles Swanton
Molecular Oncology|August 5, 2014
Tumour heterogeneity and the evolution of polyclonal drug resistanceRebecca A Burrell, Charles Swanton
Cancer Biology & Therapy|October 10, 2009
Advances in personalized therapeutics in non-small cell lung cancer: 4q12 amplification, PDGFRA oncogene addiction and sunitinib sensitivityCharles Swanton, Rebecca A Burrell
Breast Cancer Research : BCR|February 25, 2011
Breast cancer genome heterogeneity: a challenge to personalised medicine?Charles Swanton, Rebecca A Burrell, P Andrew Futreal
Cell Cycle (Georgetown, Tex.)|October 7, 2009
Chromosomal instability: a composite phenotype that influences sensitivity to chemotherapySarah E McClelland, Rebecca A Burrell, Charles Swanton
Nature|September 20, 2013
The causes and consequences of genetic heterogeneity in cancer evolutionRebecca A Burrell, Nicholas McGranahan, Jiri Bartek, et al.
Current Biology : CB|February 22, 2014
Response to Bakhoum et alRebecca A Burrell, Sarah E McClelland, Jiri Bartek, et al.
EMBO Reports|May 19, 2012
Cancer chromosomal instability: therapeutic and diagnostic challengesNicholas McGranahan, Rebecca A Burrell, David Endesfelder, et al.
Annual Review of Genetics|October 9, 2014
Cancer: evolution within a lifetimeMarco Gerlinger, Nicholas McGranahan, Sally M Dewhurst, et al.
Pageof 2